Unvaccinated Pregnant Women Drive Surge in COVID-19 Hospitalizations

Across several nations, medical authorities are documenting a troubling pattern: pregnant women who have not received coronavirus vaccines are being admitted to hospitals at disproportionately high rates. Recent weeks have seen clusters of severe respiratory illness among expectant mothers in intensive care wards, with clinicians reporting that the overwhelming majority of these patients share one characteristic: they are unvaccinated.

In Australia, where vaccination coverage among adults ranks among the highest globally, the picture is more nuanced. National immunisation data shows that while approximately 95 per cent of Australians aged 16 and over completed an initial course, uptake among pregnant women has consistently lagged behind the broader population. Hospitals in Sydney, Melbourne and Brisbane have reported an uptick in admissions over the past quarter, prompting renewed efforts by state health departments and professional colleges to reassure expectant families about vaccine safety.

Pregnancy naturally suppresses certain immune functions to accommodate the developing foetus, leaving women more vulnerable to severe outcomes from respiratory viruses. SARS-CoV-2 has repeatedly demonstrated a capacity to exploit these physiological changes, with studies linking infection during pregnancy to higher risks of preterm delivery, caesarean birth, and admission to neonatal intensive care.

Misinformation circulating on social media platforms has played a significant role in discouraging vaccine uptake among pregnant women across the country. False claims about fertility impacts, placental damage, and long-term effects on infants have been repeatedly debunked by researchers in Adelaide, Perth and other academic centres, yet the myths persist in online communities. Health authorities now emphasise that the messenger matters as much as the message, with obstetricians and midwives positioned as the most trusted voices for women weighing this decision.

A Resurgence of Severe Cases in Maternity Wards

Hospitalisation data released in recent weeks indicates that admissions among pregnant women with COVID-19 have climbed sharply in regions where the virus circulates widely. In Australia, sentinel surveillance sites in Victoria, New South Wales and Queensland feed data into national registries, with the latest figures suggesting that unvaccinated pregnant women are roughly three times more likely to require hospital care than their vaccinated counterparts, and significantly more likely to need oxygen support or ventilation.

International comparisons reinforce the Australian experience. In the United Kingdom, the UK Obstetric Surveillance System logged a marked increase in admissions during the Omicron BA.5 wave, with the steepest rise among women who had received no doses. Similar patterns emerged in the United States, where the Centers for Disease Control and Prevention reported that pregnant women with COVID-19 were five times more likely to require intensive care if unvaccinated.

Within Australian urban centres, maternity units have reorganised workflows to accommodate infectious patients. Negative pressure isolation rooms, dedicated birthing suites, and strict infection control protocols have become standard features in hospitals across Sydney's western suburbs, Melbourne's inner north, and major Brisbane facilities. Midwifery teams have undergone additional training to manage high-dependency obstetric cases, and many units now coordinate with intensive care colleagues through daily huddles, reflecting the evolving demands placed on the workforce.

Why Pregnancy Amplifies the Risks of SARS-CoV-2

The physiological changes that occur during pregnancy create a unique set of vulnerabilities to viral respiratory infections. Blood volume increases by roughly 50 per cent, heart rate rises, and the diaphragm is pushed upward by the expanding uterus, reducing lung capacity. These adaptations, essential for foetal growth, mean that any additional respiratory compromise hits harder and faster than it would in a non-pregnant person.

Research published in Australian and international journals has shown that the placenta can be directly affected by SARS-CoV-2, particularly when infection occurs in the third trimester. Placental inflammation and impaired nutrient transfer have been documented in severe cases, sometimes necessitating emergency delivery to save both mother and child. Furthermore, the prothrombotic state of pregnancy can interact dangerously with the clotting abnormalities associated with coronavirus infection.

Studies coordinated through the Murdoch Children's Research Institute in Melbourne have demonstrated that mRNA vaccines generate robust antibody responses in pregnant and breastfeeding women, with protective antibodies transferred across the placenta and through breast milk. These findings counter the misconception that vaccination during pregnancy is somehow ineffective or harmful, while also highlighting how Aboriginal and Torres Strait Islander women, who experience higher rates of chronic disease, face compounded risks that public health campaigns have only recently begun to address with culturally appropriate messaging.

Outcomes by Vaccination Status: What the Numbers Reveal

The most compelling argument for vaccination during pregnancy comes from outcomes data. Across multiple studies, vaccinated pregnant women who contract coronavirus experience milder illness, lower rates of hospitalisation, and better birth outcomes compared with their unvaccinated peers. The differences are not marginal—they are substantial enough to influence clinical guidelines and individual decision-making.

Several caveats accompany these figures. The vaccinated cohort includes women vaccinated at various stages of pregnancy and with varying numbers of doses, and the unvaccinated group may include women who declined vaccination for medical reasons that independently affect outcomes. Nevertheless, the consistency of the pattern across studies conducted in Sydney, London and Boston suggests that the protective association is robust and clinically meaningful.

Hesitancy, Misinformation, and the Path to Trust

Vaccine hesitancy among pregnant women did not emerge overnight. It stems from a combination of legitimate caution about new medical interventions, historical breaches of trust in research ethics, and a relentless stream of misinformation spread through online communities. In Australia, where general vaccine confidence is high, specific concerns about reproductive health have proven harder to dispel, partly because fertility and pregnancy are deeply personal topics where anxiety is natural.

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, alongside the Australian Technical Advisory Group on Immunisation, has consistently recommended coronavirus vaccination for pregnant women at any stage of gestation. Despite these clear endorsements, surveys conducted by universities in Brisbane and Perth have shown that up to 30 per cent of pregnant women remained uncertain or unwilling during the early phases of the rollout. The reasons cited range from fears about breastfeeding compatibility to concerns about long-term effects on children—none of which have been validated by subsequent studies.

Innovative approaches are emerging to counter these trends. Melbourne-based hospitals have introduced dedicated vaccination clinics staffed by midwives who can answer questions in a non-judgmental setting, while partnerships with Aboriginal Community Controlled Health Organisations are delivering tailored information sessions in remote communities. These grassroots efforts recognise that rebuilding trust requires more than data—it requires relationships built over time.

Clinical Guidelines and Hospital Preparedness Across Australia

The clinical response to rising hospitalisations has been coordinated through national bodies and adapted at the state level. The Australian Health Protection Principal Committee continues to review evidence and issue recommendations, while individual jurisdictions implement protocols suited to their hospital networks. In New South Wales, all public maternity units have adopted a unified screening and isolation policy for COVID-positive pregnant women, ensuring consistent care regardless of where a patient presents, and similar frameworks operate across Victoria and Queensland.

Therapeutic options have also expanded. Oral antiviral medications have been added to the Pharmaceutical Benefits Scheme, making them accessible and affordable for pregnant women who test positive and meet specific clinical criteria. This represents a significant shift from earlier phases of the pandemic when treatment options were largely limited to hospital-based interventions that carried logistical challenges for rural patients in the Northern Territory and far west of New South Wales.

Workforce planning has become a critical component of preparedness. Midwives and obstetricians have received training in high-dependency care, and simulation exercises are now standard in major hospitals to prepare for obstetric emergencies involving respiratory failure. As coronavirus surveillance continues, the goal remains ensuring that no matter how many patients present, the system retains the capacity to provide safe, individualised care across every region of the country.